Rong Jiang

Impact of Cellular miRNAs on Circulating miRNA Biomarker Signatures

Radha Duttagupta, Rong Jiang, Jeremy Gollub et al. · PLoS ONE · 2011 · 311 citations · Full text

Medicine, Molecular Biology, Oncology +15

Secondary cytoreduction followed by chemotherapy versus chemotherapy alone in platinum-sensitive relapsed ovarian cancer (SOC-1): a multicentre, open-label, randomised, phase 3 trial

Tingyan Shi, Jianqing Zhu, Yanling Feng et al. · The Lancet Oncology · 2021 · 227 citations

Medicine, Gynecology, Oncology +16

Resveratrol inhibits lung cancer growth by suppressing M2-like polarization of tumor associated macrophages

Liwei Sun, Bonian Chen, Rong Jiang et al. · Cellular Immunology · 2016 · 156 citations

Medicine, Oncology, Pharmacology +14

A Risk Model for Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer: An Evidence-Based Proposal for Patient Selection

Wen‐Juan Tian, S. Dennis, Jalid Sehouli et al. · Annals of Surgical Oncology · 2011 · 128 citations

Medicine, Gynecology, Surgery +17

Genome-Wide Maps of Circulating miRNA Biomarkers for Ulcerative Colitis

Radha Duttagupta, Sharon DiRienzo, Rong Jiang et al. · PLoS ONE · 2012 · 112 citations · Full text

Life Sciences, Molecular Biology, Molecular Medicine +17